🏒🇺🇸 BioStem is proud to support our heroes on and off the ice! As a sponsor of the Florida Panthers' Seats For Service program, we donate 4 tickets to every home game to honor and thank our active duty and veteran military service members. It’s a small token of appreciation for their incredible sacrifice and service. Know someone who deserves a night out at the rink? Nominate them here: 🔗 https://hubs.ly/Q03fzp_L0 #SeatsForService #BioStemCares #FloridaPanthers #MilitaryAppreciation #VeteranSupport #ProudSponsor
BioStem Technologies (OTC: BSEM)
Biotechnology
Pompano Beach, FL 2,607 followers
We Manufacture Products That Change Lives
About us
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
- Website
-
http://www.biostemtechnologies.com
External link for BioStem Technologies (OTC: BSEM)
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Pompano Beach, FL
- Type
- Public Company
- Founded
- 2014
- Specialties
- Biotechnology, Stem Cell Therapy, and Regenerative Medicine
Locations
-
Primary
2836 Center Port Circle
Pompano Beach, FL 33064, US
Employees at BioStem Technologies (OTC: BSEM)
-
Tom Dugan
Partner at 360 Life Sciences Advisors/Chairman and CEO
-
Michael Fortunato, CPA
CFO at BioStem Technologies | CPA, SEC Reporting, M&A Due Diligence
-
Patrick Daly
Global VP & GM @ IQVIA | Executive Advisor, MedTech Pappas Capital
-
Brandon Poe
Chief Financial Officer at Midi Health
Updates
-
📣 Great News for Patients and Providers! The Medicare Local Coverage Determination (LCD) for Skin Substitutes has officially been postponed until January 1, 2026. 🙌 This delay means patients who depend on advanced wound care products like amniotic tissue allografts will continue to have access to the treatments they need — without disruption to their benefits. 💪 At BioStem, we remain committed to supporting clinicians and the patients they serve, and we applaud the decision to allow more time for thoughtful policy development. 📰 Read more: https://hubs.ly/Q03h0Fzd0 #WoundCare #MedicareCoverage #PatientAccess #HealthcareNews #BioStem #VENDAJE #AmnioticAllografts #BioREtain #BSEM
-
-
🚀 We’re Growing – Join The Stem! 🌱 BioStem is on a mission to transform wound care, and we're looking for passionate, driven individuals to join our expanding team. With exciting new positions now open across multiple departments, there’s never been a better time to grow your career with us. 🔍 Explore our open roles: https://hubs.ly/Q03gsn1k0 📍 Be part of something that’s changing lives, one allograft at a time. #JoinTheStem #BioStemTechnologies #NowHiring #CareersInBiotech #WoundCareInnovation #HiringAlert
-
-
🏒🇺🇸 BioStem is proud to support our heroes on and off the ice! As a sponsor of the Florida Panthers' Seats For Service program, we donate 4 tickets to every home game to honor and thank our active duty and veteran military service members. It’s a small token of appreciation for their incredible sacrifice and service. Know someone who deserves a night out at the rink? Nominate them here: 🔗 https://hubs.ly/Q03fzvJ80 #SeatsForService #BioStemCares #FloridaPanthers #MilitaryAppreciation #VeteranSupport #ProudSponsor
-
-
📣BioStem Technologies (OTC: BSEM) will report its Q4 and Full-Year 2024 financial results on Monday, April 14, 2025, at 4:30 PM ET via conference call. 2024 was a landmark year for BioStem, with significant growth in revenue, operational scale, and strategic positioning. This call will provide insights into our performance, milestones, and outlook for 2025. 🗓️ Date: April 14, 2025 🕟 Time: 4:30 PM ET 🔗 Click here for full details: https://hubs.ly/Q03glCDC0 #BSEM #InvestorRelations #EarningsCall #BiotechStocks #RegenerativeMedicine #LifeSciences #GrowthStrategy #AmnioticTissue #Q4Results #FinancialDisclosure
-
-
BioStem Technologies (OTC: BSEM) reposted this
PLEASE SHARE! 😳 I cannot, in good faith, let a wound healing modality that is used by Wound Care Plus, LLC to heal people that have already failed their ability to heal themselves, go by the wayside in the population I care for. Pressure ulcers and other wound types benefit from CAMPs in the sickest of the sick, the nation’s retire poor, often forgotten, and underserved. I see their faces when I go to clinic. I see their wounds. I KNOW we make a difference. Now we can provide access to all, expand coverage for grafts, and protect the #MedicareTrustFund. THIS is why we published this article. THIS is why we make these recommendations on how to make it ALL happen with fiscal responsibility. THIS is why we CANNOT let the proposed LCD go through! Thank you to William H. Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA, CWSP for leading this publication and allowing the rest of us to weigh in. David Armstrong Dr. Windy Cole, DPM, CWSP, FFPM RCPS(Glasg) Naz Wahab Jeffrey Niezgoda #CAMPs #wound #woundhealing #woundcare #healing
-
🌟 We’re excited to announce that BioStem Technologies will be exhibiting at the upcoming Diabetic iLimb Salvage Conference (DLS) in Washington, D.C. 🗓️ Join us April 10–13 to discover how our advanced allograft solutions—powered by our proprietary BioREtain® process—are helping in the treatment of chronic wounds and transforming lives. 📍 Stop by our booth to meet the team, learn about VENDAJE® and our other innovations, and see the science behind better healing outcomes. #DLS2025 #WoundCare #LimbSalvage #BioStemTechnologies #VENDAJE #PodiatryCare #ChronicWoundHealing #BSEM
-
-
📍 We’re heading to Desert Foot East! 🗓️ April 5th-6th, 2025 📍 Marriott at Glenpointe, NJ BioStem is proud to attend Desert Foot East, where the nation's top clinicians, researchers, and innovators in limb salvage and wound care come together. We’re excited to showcase how our cutting-edge amniotic tissue allografts—VENDAJE, VENDAJE AC, and AmnioWrap2—are transforming outcomes in chronic wound management. Stop by our booth to learn about our BioREtain™ process, experience our interactive 3D technology, and see how BioStem is redefining healing. Let’s connect, collaborate, and advance wound care—together. #DesertFootEast #WoundCareInnovation #LimbSalvage #BioStem #VENDAJE #AmnioWrap2 #BioREtain #ChronicWounds #HealingRedefined #BSEM
-
-
🩹 Wound care isn’t one-size-fits-all—and neither is BioStem’s approach. From chronic diabetic ulcers to acute surgical wounds, every wound presents unique challenges. That’s why BioStem offers amniotic tissue allografts designed to meet the diverse needs of wound care professionals. ➡️ In our latest blog, we break down how our products—VENDAJE® and VENDAJE AC®,—can be used as a covering in the treatment of a variety of wounds. ✅ Chronic Wounds ✅ Acute Traumatic Wounds ✅ Surgical Wounds ✅ Burn Wounds 📖 Dive in and learn how BioStem is simplifying wound complexity with innovation and science. 🔗 https://hubs.ly/Q03fmYV50 #WoundCare #ChronicWounds #AcuteWounds #Allografts #BioREtain #BioStem #VENDAJE #HealingInnovation #BSEM
-
-
🚨 Big news from BioStem Technologies! 🚨 We’re proud to announce that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for two new U.S. patent applications! 🇺🇸🧬 🔬 These patents strengthen our intellectual property portfolio to: ✅ 43 issued patents ✅ 26 pending applications 💡 The new patents protect innovations in: 🧫 Micronized placental compositions ⚙️ Our proprietary BioREtain® processing method This is a major step forward in our mission to revolutionize wound care. 🌱💉 👉 Read the full press release: https://lnkd.in/eW372sZw #BioStem #Innovation #WoundCare #RegenerativeMedicine #Biotech #Patents #IntellectualProperty #BioREtain #HealingStartsHere #BSEM
-